Centering Pregnancy with Care Navigation for Pacific Islanders
Exploring the Feasibility of Centering Pregnancy with Care Navigation and the Preliminary Effectiveness to Improve Prenatal and Postpartum Appointment Attendance, Maternal and Infant Outcomes, and Access to Social Support Services
This study is testing a group prenatal program with extra support for Marshallese women in the U.S. to see if it can help reduce preterm births and improve their overall care during and after pregnancy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Arkansas Academic / other |
| Locations | 1 site (Fayetteville, Arkansas) |
| Trial ID | NCT05645549 on ClinicalTrials.gov |
What this trial studies
This study aims to explore the feasibility of a group-based prenatal program called Centering Pregnancy, combined with care navigation, specifically for Marshallese women in the United States. It addresses the high rates of preterm birth and low birthweight among Pacific Islanders by providing early and consistent supportive care throughout the pregnancy continuum. The study will assess its effectiveness in improving prenatal and postpartum care attendance, reducing preterm births, and enhancing access to social support services. A mixed-method approach will be utilized with two groups of participants matched on propensity scores.
Who should consider this trial
Good fit: Ideal candidates for this study are Marshallese women who are 18 years or older and are pregnant between 12 to 14 weeks of gestation.
Not a fit: Patients with high-risk pregnancies requiring specialized care or those using fertility treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved maternal and infant health outcomes for Pacific Islanders.
How similar studies have performed: Emerging literature suggests that similar group-based prenatal programs have shown promise in improving maternal and infant health outcomes, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women who self-report as Marshallese * 18 years of age or older * pregnant (12-14 weeks gestation). Exclusion Criteria: * conception with the use of fertility treatments * high-risk pregnancy that requires a transfer to a high-risk clinic * multiple gestations (i.e. pregnant with more than one infant) * use of medications known to influence fetal growth (e.g., glucocorticoids, insulin, thyroid, hormones
Where this trial is running
Fayetteville, Arkansas
- University of Arkansas for Medical Sciences-Northwest — Fayetteville, Arkansas, United States (Recruiting)
Study contacts
- Principal investigator: Britni L Ayers, PhD — University of Arkansas for Medical Sciences Northwest
- Study coordinator: Britni L Ayers, PhD
- Email: blayers@uams.edu
- Phone: 479-644-1096
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.